Asia-Pacific
A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
A new action filed by Nokia against Asus and a landmark ruling on counterfeits by South Africa’s Supreme Court were also among the top talking points
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsEarly adaptation to manage an unpredictable transition is vital, say Linh Duy Mai, Giang Hoang Bach, and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins -
Sponsored by Saint Island International Patent & Law OfficesTony Tung-Yang Chang of Saint Island International Patent & Law Offices says plant variety holders will have welcomed the ruling, which resolves previous divergence in local courts over the methodology for assessing infringement
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Eeshani Sharma of RNA, Technology and IP Attorneys explain how India’s legal framework applies to video game characters and question whether it needs to ‘level up’, given the industry’s rapid evolution
-
Sponsored by Uni-intel Patent and Trademark Law FirmGump Wang of Uni-intel Patent and Trademark Law Firm explores the strategic value of utility models, which have strong enforcement potential and play a crucial role in China’s patent system
-
Sponsored by AFD China Intellectual Property Law OfficeLinlin Sun and Xia Zheng of AFD China Intellectual Property Law Office cite two key Chinese Supreme People’s Court cases to clarify the conditions under which supplementary experimental data is accepted
-
Sponsored by DEQI Intellectual Property Law CorporationChen Shihua of DEQI Intellectual Property Law Corporation explains China's patent term compensation system, which includes a patent term adjustment for delays and a patent term extension for pharmaceutical patents requiring regulatory approval
